Neonatal hypoxic ischemic brain injury is a significant cause of mortality and lifelong neurological morbidity. Despite its public health significance, little is know about the underlying molecular pathways linking hypoxia to neuronal ischemia and cell death. In this issue of Neurotoxicity Research, Li et al. show that the integrin b8 is upregulated in cultured astrocytes in response to hypoxia, which subsequently activates a TGFb-dependant neuroprotective pathway. These findings support a novel function for astrocyte-derived integrin b8 and sheds light on the molecular mechanisms underlying hypoxic ischemic brain injury.
TGFb-mediated Cytoprotection
TGFb is a pleotropic cytokine with well-characterized cytoprotective and apoptotic effects (Annes et al. 2003; Flanders et al. 1998; Unsicker and Krieglstein 2002) . Whether TGFb promotes cell survival or induces apoptosis depends largely on the cellular and environmental context, as well as the specificity of TGFb activation and signaling. This specificity is achieved through various mechanisms including pericellular extracellular matrix localization, regulated liberation of active TGFb from its latent form, and a vast array of intracellular signaling molecules integrating TGFb effects on target tissues. The integrin avb8 is a critical activator of TGFb in vitro and in vivo. Using cell culture assays, Cambier et al. (2005) showed that astrocyte-derived avb8 binds to and activates TGFb, which then transactivates vascular endothelial cell TGFb dependent signaling. Conditional deletion of b8 from dendritic cells abrogates TGFb-mediated activation of regulatory T cells and results in an immunophenotype identical to that found in TGFb knockout mice (Travis et al. 2007 ). Mice with a mutated form of TGFb1 blocking integrin-mediated activation develop a phenotype identical to that of TGFb1 null mice (Yang et al. 2007 ) and similar to that of av or b8 deficient mice (Bader et al. 1998; Zhu et al. 2002a, b) . Finally, genetic loss of TGFb in mice results in apoptotic neuronal loss accompanied by diffuse astrogliosis, and increased neuronal susceptibility to kainic acid-induced excitotoxic injury (Brionne et al. 2003) . Moreover, in vivo TGF-b1 administration in mice protects against ischemic brain injury (McNeill et al. 1994; Zhu et al. 2002a, b) , and overexpression of TGFb1 from astrocytes protects against excitotoxic neuronal injury (Brionne et al. 2003) . While these experiments support b8's role in the activation of TGFb, and TGFb's role in neuroprotection, there has been little direct evidence demonstrating transcellular activation of neuroprotective signaling pathways by b8. Li et al. (2009) provide such evidence. They show that in the presence of b8 expressing astrocytes, TGFb protects against hypoxia-induced apoptotic cell death, in part by upregulating canonical antiapoptotic proteins BCL2 and BCLxl. Importantly, BCLxl is induced by TGFb1 via TGFb receptor, ALK1 activation of NF-kappaB, promoting neuronal survival after injury (König et al. 2005 ). It will be interesting to see if this same b8-TGFb-ALK1 pathway is important for neuronal maintenance and for protection against hypoxic ischemic injury in vivo. 
TGFb Activation
As was previously shown by other groups (Cambier et al. 2005; Mobley et al. 2009 ), Li et al. (2009) demonstrate that astrocyte-derived b8 activates TGFb. Different from other studies (Cambier et al. 2005) , however, they found that neither matrix metaloprotease (MMP) inhibition nor b8 knockdown could completely abrogate TGFb activation. While the authors note this may be due to ineffective MMP inhibition, or due to incomplete b8 knockdown, it is also possible that alternative activators of TGFb are upregulated in response to hypoxia, such as other integrins or receptors. For example, the VEGF co-receptor, neuropilin 1 (Nrp1) is highly expressed on neurons, regulates neuroprotection in response to hypoxia (Oosthuyse et al. 2001) , and was recently found to bind to and activate TGFb (Glinka and Prud'homme 2008) . Interestingly, there are numerous parallels between Nrp1 and b8. For instance, Nrp1 and b8 knockouts have similar cerebrovascular phenotypes. Also, the adult neurological phenotype of av or b8 deficient mice (McCarty et al. 2005; Proctor et al. 2005; Mobley et al. 2009 ) is strikingly similar to that of mice with deletion of the hypoxia-response element in the VEGF promoter (Oosthuyse et al. 2001) , where hypoxia-induced VEGF was found to have a neuroprotective role mediated in part through neuronal Nrp1. Considering these parallels, it will be interesting to determine whether neuro-glial Nrp1 can specifically activate TGFb in response to hypoxia, and whether this occurs in the context of the b8-TGFb interaction. Li et al. (2009) show that astocytic b8 is upregulated in response to hypoxemia and that the timing of hypoxiainduced TGFb activation mirrors peak expression levels of b8. Why might b8 expression be responsive to hypoxia/ ischemia? During development, b8 plays an essential role in vascular ingression and remodeling in the brain (Zhu et al. 2002a, b; Proctor et al. 2005) . Here, it is plausible that glialderived b8 regulates neovascularization, coupling the metabolic needs of developing neuroepithelial cells to the vasculature that supplies oxygen and nutrients. It is tempting to speculate that b8 plays a similar dual role in regulating neo-vascularization and neuronal survival in response to hypoxic damage. How does hypoxia signal astrocytes to upregulate b8? Based on the observations of Li et al. (2009) , b8 may have direct or indirect autocrine signaling effects through TGFb. TGFb and hypoxia cooperatively signal through hypoxia inducible factor (HIF)-1a to regulate transcription of endothelial-derived VEGF, and control angiogenesis and endothelial apoptosis (Ferrari et al. 2006; Sánchez-Elsner et al. 2001 ). HIF1a and its major target gene, VEGF, are upregulated in response to hypoxia/ ischemia, and may protect against neuronal cell death in this setting (Sheldon et al. 2009 ). Considering these recent reports, it will be important to determine whether b8 is involved in regulation of HIF1a and VEGF, and alternatively how hypoxia, HIF1a and VEGF may regulate expression of b8. This line of study may more fully elucidate the pathophysiology of hypoxic ischemic brain injury and could help identify novel treatment targets. Taken together the findings of Li et al. (2009) , one may speculate that b8 is critically important for neuronal maintenance and protection against hypoxic insult in vivo. Testing of this hypothesis will require astrocyte specific deletion of b8, and in vivo characterization of these mice in various injury paradigms including hypoxia/ischemia brain injury.
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